Status:
UNKNOWN
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
Lead Sponsor:
Xijing Hospital
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
This study seeks to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke
Detailed Description
a randomized, double-blind, placebo-controlled phase II multicenter trial is conducted to evaluate the efficacy and safety of mildronate injection in patients with acute ischemic stroke. patients will...
Eligibility Criteria
Inclusion
- \- have a clinical diagnosis of acute ischemic stroke have CT or MRI brain imaging NIHSS scores:5\~22 on the first stage
Exclusion
- \- have other intracranial pathologies are pregnant or nursing have significant drug or alcohol misuse have been in a clinical trial in the past 3 months are unlikely to be available for follow-up have been given thrombolytic therapy or medication forbidden by study protocol have a neurological or psychiatric disease
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01800357
Start Date
January 1 2013
End Date
August 1 2014
Last Update
February 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Department of Neurology , Xijing Hospital
Xi'an, Shaanxi, China, 710032